ATNM
Actinium Pharmaceuticals (Delaware) (ATNM)
$66
About Actinium Pharmaceuticals (Delaware) (ATNM)
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Details
Daily high
$1.78
Daily low
$1.66
Price at open
$1.77
52 Week High
$10.24
52 Week Low
$1.33
Market cap
51.7M
Dividend yield
0.00%
Volume
85
Avg. volume
311,355
P/E ratio
-1.09
Actinium Pharmaceuticals (Delaware) News
Details
Daily high
$1.78
Daily low
$1.66
Price at open
$1.77
52 Week High
$10.24
52 Week Low
$1.33
Market cap
51.7M
Dividend yield
0.00%
Volume
85
Avg. volume
311,355
P/E ratio
-1.09